Alzheimer's & Dementia·7 OctNetwork-dependent remote effects and local tau burden jointly shape neuronal dysfunction in Alzheimer's diseaseStudy in peopleMechanismsPaper
medRxiv·1 OctGantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer diseasePreprint: non-randomised trial in peopleAlzheimer's diseasePaper
Molecular Neurodegeneration·26 SepDynamic [¹⁸F]PI-2620 recording facilitates prediction of β-amyloid positivity and simultaneous staging of tau and neurodegenerationCohort study in peopleBiomarkersPaper
PsyArXiv·25 SepRemote Digital Cognitive Assessment in a Trial-Ready Alzheimer’s Cohort: A Scalable Approach for Early Intervention StudiesPreprint: cohort study of 162 peopleAlzheimer's diseasePaper
Alzheimer's & Dementia·24 SepTechnology-natives and technology-adopters: Age differences in remote cognitive assessment in Alzheimer diseaseCohort study of 444 peopleAlzheimer's diseasePaper
CNS Drugs·15 SepFrom Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer's DiseaseReviewInterventionsPaper
Aging Brain·14 SepHealth-related factors and their impact on blood-based biomarkers of Alzheimer's diseaseCohort study of 116 peopleAlzheimer's diseasePaper
Alzheimer's & Dementia·10 SepRemote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studiesCohort study of 123 peopleAlzheimer's diseasePaper
Lancet·3 SepNatural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical studyCohort study of 4,804 peopleDown syndromePaper
Neurology·1 SepLongitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down SyndromeCohort study of 59 peopleMechanismsPaper
bioRxiv·31 AugCerebrospinal fluid YWHAG:NPTX2 ratio predicts clinical severity and future phenoconversion in frontotemporal lobar degenerationPreprint: cohort study in peopleBiomarkersPaper
medRxiv·26 AugGlucagon-like peptide-1 receptor agonist initiation and risk of clinically recorded Alzheimers disease-type dementia in older adults with type 2 diabetes: a target trial emulation using causal machine learningPreprint: cohort study of 6,328 peopleGLP-1 receptor agonistsPaper
Journal of Intellectual Disability Research·18 AugFrailty in Adults With Down Syndrome: Cognitive, Functional and Biomarker AssociationsCross-sectional study of 148 peopleDown syndromePaper
Alzheimer's & Dementia·8 AugAPOE and genetic risk variants influence Alzheimer's disease onset in carriers of an extra copy of APP, with and without Down syndromeStudy in peoplePopulationsPaper
Brain Communications·5 AugEducational attainment and sex modulate clinical outcomes in genetic frontotemporal dementiaStudy in peoplePopulationsPaper
AAIC 2025 Abstract·7 JanAlpha‐Synuclein Pathology in Down Syndrome‐Associated Alzheimer's Disease: Insights from Seed Amplification Assay and NeuropathologyStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·26 DecTMEM106B modulates disease severity in genetic frontotemporal dementia phenoconvertersStudy in peoplePopulationsPaper
AAIC 2025 Abstract·26 DecValidation of Amyloid Chronicity in Autosomal Dominant Alzheimer DiseaseStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecDiscrepancies in Assessing Intellectual Disability Levels in Adults with Down syndrome: Implications for Dementia DiagnosisStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecStructure‐function decoupling in genetic frontotemporal dementiaStudy in peopleMechanismsPaper